Focus: ResMed is a San Diego-based medical device company with 5,001-10,000 employees, publicly traded, focusing on respiratory, sleep, and cloud-connected care solutions. It is a market leader in positive airway pressure (PAP) devices, masks, and remote monitoring systems for sleep apnea and chronic respiratory conditions.
Profile data last refreshed 10h ago · AI intelligence enriched 3w ago
Hot — 322 jobs added in 30d
Net +213 (322 new, 109 removed). Aggressive expansion phase.
Ideal for engineers, commercial operators, and supply-chain professionals seeking stability and execution excellence; less appealing to scientists expecting robust R&D labs or pipeline-driven career trajectories.
Help build intelligence for ResMed
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from ResMed's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Hold from Citi - The Globe and Mail
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Hold from Citi The Globe and Mail
Resmed Inc Stock (RMD) Moved Up by 3.01% on Aug 10: Key Drivers Unveiled - TradingKey
Resmed Inc Stock (RMD) Moved Up by 3.01% on Aug 10: Key Drivers Unveiled TradingKey
Resmed says weight-loss pills are driving sleep device demand - AFR
Resmed says weight-loss pills are driving sleep device demand AFR
Resmed Inc Stock (RMD) Closed Down by 5.22% on Aug 7: What Investors Need To Know - TradingKey
Resmed Inc Stock (RMD) Closed Down by 5.22% on Aug 7: What Investors Need To Know TradingKey
ResMed shares tumble as weak 2027 sales forecast eclipses quarterly profit beat - Reuters
ResMed shares tumble as weak 2027 sales forecast eclipses quarterly profit beat Reuters
ResMed (ASX:RMD) ClimbsHigher as Healthcare Stocks Advanced—What Matters for Long-Term Investors? - Kalkine
ResMed (ASX:RMD) ClimbsHigher as Healthcare Stocks Advanced—What Matters for Long-Term Investors? Kalkine
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo